✦ LIBER ✦

A Phase II Trial of Prolonged Oral Etoposide (VP-16) as Second-Line Therapy for Advanced and Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

✍ Scribed by Peter G. Rose; John A. Blessing; George S. Lewandowski; William T. Creasman; Kenneth D. Webster

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential prolonged oral topotecan and

✍ Peter G. Rose; Maurie Markman; Jeffrey G. Bell; Nancy L. Fusco 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Phase II trial of cisplatin as first-lin

✍ Jt Thigpen; JA Blessing; H Homesley; WT Creasman; G Sutton 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Phase II trial of clsplatin as first-lin

✍ J.Tate Thigpen; John A. Blessing; Howard Homesley; William T. Creasman; Gregory 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 331 KB

A Phase II evaluation of weekly topoteca

✍ James V. Fiorica; John A. Blessing; Louis V. Puneky; Angeles Alvarez Secord; Jam 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 142 KB

A phase II trial of radiation therapy an

✍ David H. Moore; Shamshad Ali; Wui-Jin Koh; Helen Michael; Mack N. Barnes; Caroly 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 232 KB

A phase II trial of radiation therapy an

✍ D. Moore; S. Ali; M. Barnes; W. Koh; H. Michael; C. McCourt; H. Homesley; J. Wal 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 105 KB